Effect of Irbesartan Combined with Amiodarone on the Levels of Serum Inflammatory Factors Myocardial Enzymes and NT-proBNP in Patients with Paroxysmal Atrial Fibrillation
JI Ping, WANG Ping, WU Luling
General Hospital of Jianghan Oilfield, Hubei Qianjiang 433100, China
Abstract：Objective: To analyze the effects of irbesartan combined with amiodarone on the levels of serum inflammatory factors, myocardial enzymes and amino terminal B-type N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with paroxysmal atrial fibrillation. Methods: 90 patients with paroxysmal atrial fibrillation were randomly divided into observation group and control group according to the simple random number table method after numbering with admission sequence, 45 cases in each group. The control group was given routine treatment and amiodarone, the observation group was given irbesartan combined with amiodarone treatment. The followed-up last for 12 months in both groups. The number of atrial fibrillation, maintenance rate of sinus rhythm, cardiac function [left ventricular ejection fraction (LVEF), left ventricular end diastolic diameter (LVDD), left ventricular posterior walldepth (LVPW), P wave dispersion (PD)], serum inflammatory factors, myocardial enzymes [Creatine kinase isoenzyme (CK-MB), cardiac troponin I (cTnI)], NT-proBNP levels and incidence of adverse events in the two groups were recorded. Results: The number of atrial fibrillation in the observation group was less than that in the control group at 6 months and 12 months after treatment, while the maintenance rate of sinus rhythm was higher than that in the control group (P<0.05). At the end of treatment, the LVEF in the observation group was higher than that in the control group, while the LVDD, LVPW and PD were smaller than those in the control group (P<0.05). The levels of serum HSP27, hs-CRP, IL-6, CK-MB, cTnI and NT-proBNP in the observation group were lower than those in the control group after treatment (P<0.01). The incidence of adverse events in the observation group was 24.44%, slightly higher than that in the control group (17.78%) (P>0.05). Conclusion: The combination application of irbesartan combined with amiodarone for patients with paroxysmal atrial fibrillation can significantly reduce the number of atrial fibrillation, improve maintenance rate of sinus rhythm and cardiac function, reduce the levels of inflammatory factors and NT-proBNP, restore myocardial enzymes to normal. It is safe and reliable.
季萍, 王萍, 吴璐伶. 厄贝沙坦联用胺碘酮治疗对阵发性心房颤动患者血清炎症因子及心肌酶NT-proBNP水平的影响[J]. 河北医学, 2019, 25(6): 902-906.
JI Ping, WANG Ping, WU Luling. Effect of Irbesartan Combined with Amiodarone on the Levels of Serum Inflammatory Factors Myocardial Enzymes and NT-proBNP in Patients with Paroxysmal Atrial Fibrillation. HeBei Med, 2019, 25(6): 902-906.
2019, Vol. 25 
冀公网安备13080202000677号